In vitro biomimetic HPLC and in vivo characterisation of GM6, an endogenous regulator peptide drug candidate for amyotrophic lateral sclerosis. (2018). ADMET and DMPK, 6(2), 176-189. https://doi.org/10.5599/admet.547